Champions Oncology
Hackensack, NJ, USA Specialty Founded 2007 51-200 employees 4-8 weeks
Specialty CRO focused on translational oncology services. Champions provides patient-derived xenograft (PDX) tumor models, ex vivo tumor platforms, and oncology pharmacology studies.
Services
PRECLINICAL
DISCOVERY
Therapeutic Areas
Model Organisms
Mouse
Regulatory Experience
FDA